Les risques d’évolution de la maladie psoriasique : Quiz | Site Novartis

Savez-vous que 30% des patients atteints de psoriasis développent un rhumatisme psoriasique ?Testez vos connaissances sur le psoriasis et les localisations particulières.

  1. Ritchlin CT, Colbert RA, Gladman DD. Psoriatic Arthritis. N Engl J Med. 2017;376(21):2095-6.
  2. Sanchez IM, et al. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review. Dermatol Ther (Heidelb). 2017;7(4):425-446.
  3. Merola JF, et al. Prevalence of psoriasis phenotypes among men and women in the USA. Clin Exp Dermatol. 2016;41(5):486-489.
  4. Papp K, et al. Scalp psoriasis: a review of current topical treatment options. J Eur Acad Dermatol Venereol. 2007;21(9):1151-60.
  5. Scher JU, et al. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15(3):153-66.
  6. Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983-94.
  7. Blauvelt A, Armstrong AW, Krueger GG. Essential truths for the care and management of moderate-to-severe psoriasis. J Drugs Dermatol. 2015;14(8):805-812.
  8. Kerdel F, Don F. The Importance of Early Treatment in Psoriasis and Management of Disease Progression. J Drugs Dermatol. 2018;17(7):737-42.
  9. Korman NJ. Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol. 2019. doi: 10.1111/bjd.18245.
167925 – Novembre 2021 – Copyright Novartis Pharma SAS
×

Ask Speakers